Letter From the Chair
Dear Colleagues,
Upon reflection, 2024 was a year of relative stability for the Institute that allowed for remarkable productivity. Because, for the first time in a few years, we did not have to react to overwhelming and unexpected external challenges such as COVID, we were able to focus and build upon our many strengths. We not only met but exceeded even the ‘stretch’ goals we set in our 2020-2024 strategic plan.
What We Achieved This Year
2024 News Highlights
Major Institute Programs
Explore the Institute’s four major programs: Electronic medical record Support for Public health, PCORnet, Project Viva, and the FDA Sentinel System. These programs include research in chronic disease, national research networks, lifecourse studies, and product safety, all aimed at advancing population health.
Courses and Curriculum
Institute members bring their expertise to lead several courses at Harvard Medical School and Harvard T.H. Chan School of Public Health. In 2024, faculty led 9 courses at Harvard Medical School, 8 courses at Harvard T.H. Chan School of Public Health, and 3 additional teaching activities.
Fellowship and Training Programs
The Institute is home to several pre- and post-doctoral fellowships. In 2024, we welcomed 16 new fellows, achieved 27 first‑author publications by trainees, and had 9 complete their fellowship and transition into clinical, research, and faculty roles.